[Paroxysmal nocturnal hemoglobinuria].
Kuwayama
M
M
Department of Immunoregulation, Research Institute for Microbial Diseases, Osaka University.
Kinoshita
T
T
Ohishi
K
K
D000728:Androgens / Q000627:therapeutic use; D000818:Animals; D018958:CD55 Antigens; D018957:CD59 Antigens; D003613:Danazol / Q000627:therapeutic use; D003937:Diagnosis, Differential; D017261:Glycosylphosphatidylinositols / Q000172:deficiency; D006457:Hemoglobinuria, Paroxysmal / Q000209:etiology / Q000628:therapy; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics; D009154:Mutation; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis
D000728:Androgens; D018958:CD55 Antigens; D018957:CD59 Antigens; D017261:Glycosylphosphatidylinositols; D008565:Membrane Proteins; C080086:phosphatidylinositol glycan-class A protein; D011239:Prednisolone; D003613:Danazol